ArticlePharmacology research & perspectives2025
Application of the Weibull Model to Statins for Triglyceride Management in Patients With Hyperlipidaemia.
Article in Pharmacology research & perspectives, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of the Weibull Model to Statins for Triglyceride Management in Patients With Hyperlipidaemia.Pharmacology research & perspectives · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dyslipidemia, characterized by abnormal serum cholesterol or triglyceride (TG) concentrations, is prevalent among middle-aged and older adults and contributes to atherosclerosis and increased cardiovascular risk. Although oral statins effectively decrease low-density lipoprotein cholesterol, patients with high-TG concentrations remain at significant risk for atherosclerotic cardiovascular disease. Weibull analysis, a statistical method widely applied in reliability engineering and medicine, is suitable for assessing arterial stiffness, which reflects vascular aging or deterioration. This study explored the relationship between TG concentrations and arterial stiffness via Weibull analysis in patients treated with statins (STG) and patients without statin treatment (No-STG). The mode of the Weibull distribution was greater for STG (97.8 mg/dL) than for No-STG (80.7 mg/dL). Notably, compared with No-STG patients, STG patients presented lower hazard functions for TG concentrations up to 170 mg/dL. However, above 170 mg/dL, the hazard function for STG was equal to or slightly greater than that for No-STG. These findings suggest that without statin therapy, atherosclerosis may develop at lower TG concentrations, whereas statins effectively delay its onset. However, the data also highlight the limitations of statins in significantly reducing TG concentrations. This information underscores the importance of patient education in preventing the progression of atherosclerosis. Encouraging lifestyle changes, including improved exercise and dietary habits, can complement statin therapy to optimize cardiovascular health. These findings provide a basis for promoting patient awareness and fostering the proactive management of cardiovascular risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.